GRIMES & COMPANY, INC. – Eli Lilly and Company Transaction History
GRIMES & COMPANY, INC. portfolio value:
$1.22M
portfolio value
GRIMES & COMPANY, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.48% | 18 shares | 3K | $323.35 | 3.77K |
Q2 2022 | share | Decrease | -1.18% | -45 shares | 129K | $324.23 | 3.76K |
Q1 2022 | share | Decrease | -1.96% | -76 shares | 18K | $286.37 | 3.80K |
Q4 2021 | share | 0.00% | 0 shares | 175K | $277.25 | 3.88K | |
Q3 2021 | share | Increase | +1.41% | 54 shares | 19K | $230.3 | 3.88K |
Q2 2021 | share | Increase | +0.37% | 14 shares | 165K | $228.04 | 3.82K |
Q1 2021 | share | Decrease | -17.23% | -794 shares | -65K | $184.81 | 3.81K |
Q4 2020 | share | 0.00% | 0 shares | 95K | $166.32 | 4.60K | |
Q3 2020 | share | Decrease | -0.35% | -16 shares | -76K | $145.05 | 4.60K |
Q2 2020 | share | 0.00% | 0 shares | 118K | $160.1 | 4.62K | |
Q1 2020 | share | Increase | +5.79% | 253 shares | 67K | $134.64 | 4.62K |
Q4 2019 | share | Increase | +0.67% | 29 shares | 88K | $126.91 | 4.37K |
Q3 2019 | share | 0.00% | 0 shares | 5K | $107.36 | 4.34K | |
Q2 2019 | share | Decrease | -1.30% | -57 shares | -90K | $105.74 | 4.34K |
Q1 2019 | share | Increase | +4.19% | 177 shares | 82K | $123.17 | 4.39K |
Q4 2018 | share | Decrease | -2.88% | -125 shares | 23K | $109.26 | 4.22K |
Q3 2018 | share | Increase | +1.16% | 50 shares | 99K | $100.8 | 4.34K |
Q2 2018 | share | Increase | +22.88% | 800 shares | 97K | $79.72 | 4.29K |
Q1 2018 | share | Increase | 0.00% | 3.49K shares | 270K | $71.78 | 3.49K |